An international pharmaceutical company had a new medication designed to combat insomnia going into Phase III trials and they needed sites throughout the United States to participate.
Meridien Research had several sites in the Tampa Bay area of Florida that had successfully completed insomnia studies in the past. After going through the site selection process, one site was chosen and enrollment began.
Using a combination of traditional outreach (health fairs, referring physicians and networking) and advertising/social media, Meridien Research was able to screen 27 subjects. They enrolled 10 subjects (100% of goal) within three months. The retention rate for this study was 100%.
When it comes to insomnia studies, Meridien Research doesn’t sleep on the job! Call to find out how we can enroll your sleep studies today!
About Meridien Research
Meridien Research has been offering medical research to residents of Central Florida since 2000. With six privately-owned clinical trial facilities in St. Petersburg, Tampa, Maitland and Lakeland, Meridien Research’s mission is to provide consistent, high-quality clinical research in a professional, ethical and timely manner.